Contract 36F79719D015E
Asegua Therapeutics Llc · Department Of Veterans Affairs · March 13, 2019
Asegua Therapeutics Llc was awarded a federal contract by Department Of Veterans Affairs on March 13, 2019 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 13 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 28, 2020. If all options are exercised, the contract could reach $25,000.
Contract details
- PIID
- 36F79719D015E
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 13, 2019
- Latest action
- January 28, 2020
Description
INTERIM AGREEMENT CANCELLATION.
Modification timeline
-
January 28, 2020Mod P00014$0
-
December 20, 2019Mod P00012INTERIM AGREEMENT TPR.$0
-
December 10, 2019Mod P00011INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS$0
-
September 16, 2019Mod P00008LIFECYCLE CHANGE TO PERMANENT$0
-
September 13, 2019Mod P00009INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS$0
-
September 13, 2019Mod P00010INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS$0
-
September 11, 2019Mod P00007TEMPORARY EXTENSION OF INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS$0
-
July 10, 2019Mod P0000642-2A TEMPORARY LIFE CYCLE$0
-
June 21, 2019Mod P00005INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS$0
-
June 20, 2019Mod P00004INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79719D015E?
Contract 36F79719D015E is a federal contract awarded to Asegua Therapeutics Llc by Department Of Veterans Affairs on March 13, 2019 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 13 times since the base award.
Who won contract 36F79719D015E?
Asegua Therapeutics Llc won contract 36F79719D015E from Department Of Veterans Affairs.
How much is contract 36F79719D015E worth?
Contract 36F79719D015E has obligated $0 to date but carries a potential ceiling of $25,000 if fully funded and all options are exercised.